http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2693251-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d5707f83c2cab62283a6ef3b601389e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
filingDate 2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96ad481fdc7efa94fb63d10edf3a19ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_799d4af479c1731c6a1d1c76d41213db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c853f5e01367c2e0464fcd56ee8ecb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ff47ed803d8659998377ed397dece3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_276aa092946878368aeb38c060effddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e734cd0a0e07be173f3ced6f5829f136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e73ba05fa7360ddfcc0b2405c36f69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8093d887e51319d9d3fffe1baf2e6e36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_735ac919ce3fdb933709499ad994b502
publicationDate 2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2693251-C1
titleOfInvention Method for extracting and purifying recombinant protein, an analogue of a human kappa-casein fragment having cytotoxic activity towards human cancer cells
abstract FIELD: biotechnology. n SUBSTANCE: invention relates to biotechnology, genetic and protein engineering. Method for extraction and purification of recombinant protein, analogue of human kappa-casein fragment, involves cultivation of HEK293T-producing cells expressing recombinant EL1 protein, concentration and purification of the culture medium first using cation-exchange chromatography on SP-sepharose, and then using nickel-affinity chromatography on IMAC-sepharose, successive elution from impurity proteins and target product sorbents using a system of eight buffer solutions and subsequent purification of the end product by dialysis against 150 mM NaCl. n EFFECT: invention increases specific activity and purity of the end product. n 1 cl, 7 dwg, 4 ex
priorityDate 2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2401307-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017174721-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2322505-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C8A4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218671
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID416504
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40308
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01374
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID831275
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76418691
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5WR07
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426222743
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8533
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5TM20
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6503
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8628339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211032
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29993
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426148219
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2541912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526964
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID379813
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5651
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP98073
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09225
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y0A1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61125
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19146
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID549992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454658198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10154
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XT48
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407742
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280845
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554305
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP82109
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25008
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26572
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81902
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9JM09

Total number of triples: 80.